CombiMatrix Europe

CombiMatrix Europe was a molecular diagnostics company that provided comprehensive genomic testing services, primarily focusing on chromosomal microarray analysis (CMA). As the European subsidiary of CombiMatrix Corporation, the company served clinicians and patients in the fields of prenatal health, pediatric genetics, and oncology. Its technology platform allowed for the detection of submicroscopic chromosomal gains and losses that traditional karyotyping could not identify. Key applications included miscarriage analysis (Products of Conception testing), identifying the genetic basis of developmental delays, and monitoring hematological malignancies. The company operated as a specialized laboratory service provider, facilitating advanced genetic insights across Europe. In 2017, its parent company was acquired by Invitae, resulting in the integration of CombiMatrix's diagnostic capabilities into Invitae's broader genetic testing portfolio.